This means that the automobile business will become the main business of Evergrande Health in the future. In the announcement, Evergrande Health also said that the company is making every effort to develop the new energy vehicle business, and has built a whole industrial chain of new energy vehicles covering power batteries, powertrains, advanced vehicle manufacturing, automobile sales and intelligent charging. It has top-notch core technologies in all key links, implements a global integrated research and development model, and cooperates in research and development in China, Sweden, Germany, Britain, the Netherlands, Austria, Italy, Japan, South Korea and other countries, and strives to achieve in 3-5 years.
In 20 19, the net loss of Evergrande Health was 4.95 billion yuan, of which the loss of Evergrande's new energy automobile business was 3.365438 billion yuan. It can be said that the automobile business has "dragged down" the overall performance of Evergrande Health. However, Evergrande believes that Evergrande's new energy automobile business is still in the stage of expanding investment, and it is normal to increase related expenses and interest expenses such as purchasing fixed assets and equipment. Evergrande's senior health officials also expressed quite confidently that although the sales of Evergrande's Health Valley are the company's main income at present, it may become one of Evergrande's main income when it sells cars in 1 year.
For a long time, many people inside and outside the industry have various views on Evergrande's car-building, but at present, Evergrande is making continuous progress in capital investment, technical reserve and hardware construction, and Evergrande also thinks that its "new energy automobile business has been fully investigated and demonstrated in the market and has sufficient strategic determination and confidence". It is reported that Hengchi 202 1 full range of products will be mass-produced. (Text/car home? Cai Liyuan)